40
Participants
Start Date
July 31, 2023
Primary Completion Date
December 27, 2027
Study Completion Date
December 31, 2031
Cytoreductive nephrectomy±metastasectomy
Partial or complete nephrectomy by open, laparoscopic, or robotic approach and/or metastasectomy Tumor tissue, blood, urine and stool specimens for translational biomarker research will be sample at baseline, surgery, after induction therapy, and after 3 months of maintenance therapy.
Cytoreductive nephrectomy±metastasectomy
Partial or complete nephrectomy by open, laparoscopic, or robotic approach and/or metastasectomy Tumor tissue, blood, urine and stool specimens for translational biomarker research will be sample at baseline, surgery, after induction therapy, and after 3 months of maintenance therapy.
Human-derived materials sampling
Tumor tissue, blood, urine and stool specimens for translational biomarker research will be sample at baseline, after induction therapy, and after 3 months of maintenance therapy.
NOT_YET_RECRUITING
Gangnam Severance Hospital, Seoul
RECRUITING
Yonsei University Health System, Severance Hospital, Seoul
NOT_YET_RECRUITING
Yongin Severance Hospital, Yongin-si
Yonsei University
OTHER